Affiliates of Siris Capital Complete Combination of Mitel Mobile with Xura and Ranzure Networks to Create the New Mavenir Systems
Today affiliates of Siris Capital Group, LLC (“Siris Capital” or “Siris”) and Xura, Inc. (“Xura”) announced the completion of the acquisition of Mitel Mobility, Inc. (“Mitel Mobile”), a division of Mitel Networks Corporation (“Mitel”, Nasdaq: MITL, TSX: MNW). This announcement follows the completion of Xura’s acquisition of Ranzure Networks, Inc. (“Ranzure”) on February 1, 2017, and the previously announced divestiture of Xura’s non-core enterprise messaging business (Xura Secure Communications, GmbH) on February 17, 2017. The transactions position the new Mavenir as a 100% carrier-focused solutions provider with a “future proof” and 5G ready software-based portfolio across every layer of the mobile network infrastructure stack. Mavenir will be headquartered in Richardson, Texas and led by Xura’s CEO, Pardeep Kohli.
Pardeep Kohli, President and CEO of Mavenir, commented:
“The completion of these transactions to form the new Mavenir represents a significant milestone in the evolution of Xura, Mitel Mobile, and Ranzure. These transactions bring together three complementary companies to establish a new industry leader that is singularly focused on accelerating and redefining network transformation for service providers. We are delighted to move forward as one company with a strong and shared commitment to customer enablement and success.”
The New Mavenir Systems
The new Mavenir positions itself as an industry leader in cloud-proven, NFV, SDN, and 5G ready software-based solutions across every layer of the network infrastructure stack, helping CSPs drive revenues and operating efficiencies by enabling increased network optimization, flexibility and scalability. Mavenir offers a comprehensive, fully-virtualized solution set across Voice-over-LTE (“VoLTE”), Voice-over-WiFi (“VoWiFi”), video, voicemail, advanced messaging, security, radio access network, and packet core. With its broad and complementary solutions offering, Mavenir will enable customers to focus on service innovation and monetization, while delivering the optimization to handle the next wave of exponential traffic growth from 5G and Internet of Things (“IoT”) applications and services.
Hubert de Pesquidoux, the executive chairman of Mavenir and executive partner at Siris Capital, commented:
“Today is the first of many exciting days for our newly established company. In the coming weeks and months, we look forward to integrating the businesses and moving forward as a single team dedicated to delivering on the promise of our technology and innovation. With a fully-virtualized, cloud-proven and 5G ready product portfolio, an accomplished leadership team, a deep technical bench, a cadre of over 2,000 dedicated employees worldwide, and the firm support of Siris Capital, the new Mavenir is well-positioned to bring the next wave of mobile network solutions to market and help transform the digital communications industry.”
Concluding, Pardeep Kohli said:
“Both Xura and Mitel Mobile have enduring track records of market-leading innovation and customer commitment, providing a solid foundation to realize Mavenir’s mission of partnering with its customers to deliver tomorrow’s vision today. I am honored and excited to lead the new Mavenir, and I look forward to working collaboratively with our customers as they transform their networks and bring differentiated services and solutions to market.”
– Ends –
About Mavenir Systems | Mavenir
As a trusted partner, Mavenir accelerates and redefines network transformation for service providers. By offering a comprehensive product portfolio across every layer of the network infrastructure stack — from 5G application/service layer to the RAN and packet core – Mavenir leads the way in evolved, cloud-proven networking solutions enabling innovative and secure new experiences for end users. Through its industry first VoLTE, VoWiFi, Advanced Messaging and Cloud RAN solutions, Mavenir’s platform enables service providers to successfully deliver tomorrow’s vision today and realize new revenue streams and operating efficiencies. www.mavenir.com
About Siris Capital Group, LLC | Siris Capital
Siris Capital is a leading private equity firm focused on making control investments in data, telecommunications, technology and technology-enabled business service companies. Integral to Siris' investment approach is its partnership with exceptional senior operating executives, or Executive Partners, who work with Siris to identify, validate and operate investment opportunities. Their significant involvement allows Siris to partner with management to add value both operationally and strategically. To learn more, visit us at www.siriscapital.com.
SVP, Head of Corporate Marketing
M: +44 (0) 7894604040
Om Business Wire
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Celltrion Receives Positive CHMP Opinion for Herzuma® for Trastuzumab Biosimilar15.12.2017 22:13 | Pressemelding
Celltrion, Inc. (KOSDAQ: 068270) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending that Herzuma® (trastuzumab biosimilar) be granted marketing authorization in the European Union (EU) for the treatment of patients with early breast cancer, metastatic breast cancer, or metastatic gastric cancer whose tumors have either HER2 overexpression or HER2 gene amplification. The CHMP’s opinion will now be sent to the European Commission (EC) for final review. Herzuma® is a biosimilar to Herceptin®i, a breast cancer and gastric cancer treatment antibody biologic drug developed by Genentech and marketed by Roche. Herceptin® is a blockbuster drug which had worldwide sales of CHF 6.8 billionii (US$6.8 billion) in 2016, of which CHF 2.1 billioniii (US$2.1 billion) was in
Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn’s disease15.12.2017 12:34 | Pressemelding
Takeda Pharmaceutical Company Limited (TSE: 4502) (“Takeda”) and TiGenix NV (Euronext Brussels and NASDAQ: TIG) (“TiGenix”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), in conjunction with the Committee for Advanced Therapies (CAT), has adopted a positive opinion recommending a marketing authorization (MA) for investigational compound Cx601 (darvadstrocel). Cx601 is expected to be indicated for the treatment of complex perianal fistulas in adult patients with non-active/mildly active luminal Crohn’s disease, when fistulas have shown an inadequate response to at least one conventional or biologic therapy.2 This recommendation marks the first allogeneic stem cell therapy to receive a positive CHMP opinion in Europe. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/201712
Bitcoin Romania and Twispay Announce Integration Partnership Providing Users with the Ability to Purchase Bitcoin with Bank Cards15.12.2017 12:21 | Pressemelding
Bitcoin Romania, leading Eastern European Bitcoin exchange & brokerage firm, and Twispay, Swiss-owned European payment processor and FinTech pioneer, today announced the availability of a payment integration that allows a global clientele to acquire Bitcoin and Ethereum cryptocurrencies using Visa and Mastercard bank cards. Unprecedented in Romania, this is one of the first East-Central European integration partnerships that allow consumers to use their cards to purchase cryptocurrency. Until recently, investors could only acquire cryptocurrencies through bank transfers and cash deposits, but the volatility of cryptocurrency markets dictates the need for additional operational flexibility. Investors require faster, safer, more reliable, and more comfortable ways to complete purchases. “One minute can make the difference between a million lost and a million earned. That is pr
Upon Conclusion of the Fourth Annual Forum for Promoting Peace in Muslim Societies, Scholars and Intellectuals Visit the Louvre Abu Dhabi Museum15.12.2017 11:38 | Pressemelding
A high-level delegation of dignitaries, scholars and intellectuals participating in the fourth annual Forum for Promoting Peace in Muslim Societies, visited the Louvre Abu Dhabi museum. The delegation was headed by H.E Mustafa Ceric, former Grand Mufti of Bosnia; alongside Sheikh Mohammad Mukhtar Ould Imbala, Head of Mauritania’s Fatwa & Grievances Supreme Council; H.E Amar Mirghani Hussein, Sudanese Minister of (religious) Guidance and Endowments; and H.E Salho Jay, Imam of the Juma Masjid in South Africa. The Forum was held in Abu Dhabi from 11-13 December 2017, with the participation of more than 700 scholars, intellectuals and religious dignitaries from around the world. This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171215005255/en/ Group Photo of the Scholars and Intellectuals during their visit to the L
Kennedy Wilson Acquires 124-Unit Northbank Apartments in Dublin, Ireland for €45 Million15.12.2017 11:00 | Pressemelding
Global real estate investment company Kennedy Wilson (NYSE: KW) announces that it has acquired Northbank Apartments, a wholly-owned 124-unit apartment community in Dublin’s North Docks, for €45 million from Jarmar Properties Limited (In Receivership) acting through David Carson of Deloitte as Statutory Receiver, the lender being the National Asset Management Agency (“NAMA”). Situated in Dublin’s North Docks, Northbank is located just 50 meters from Kennedy Wilson’s existing 84-unit Liffey Trust apartments. The two buildings benefit from great transport links as the LUAS Red line is immediately adjacent connecting to Dublin’s city centre and main train stations in five minutes. “The successful acquisition of Northbank in such close proximity to our Liffey Trust asset allows us to leverage our existing presence and implement our value-add asset management strategy, including a
AML BitCoin Enters Phase II of ICO15.12.2017 09:00 | Pressemelding
NAC Foundation, LLC announces today that the initial coin offering for the AML BitCoin – the world’s only patent-pending compliant digital currency – has been extended for another month to accommodate a torrent of last minute, new coin purchasers and the demands of thousands of current owners of the coin, who have had difficulty navigating the process of establishing the specialized wallet required to hold the innovative digital currency. This second phase of the AML BitCoin initial coin offering will see an increase in the price of the coin, from US $1.00 to US $1.25. The company has already been contacted by prospective purchasers in the slightly higher priced Phase II, and anticipates a further price increase to US $1.50 within a week or two. HitBTC, one of the world’s largest and most active digital currency exchanges, was prepared to list the AML BitCoin for trading on
I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.Besøk vårt presserom